24 results
424B5
ACRS
Aclaris Therapeutics Inc
10 Jun 21
Prospectus supplement for primary offering
4:26pm
or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 662∕3% of the outstanding voting stock … directors may call a special meeting of stockholders.
Our amended and restated bylaws also provide that stockholders seeking to present proposals before
424B5
ACRS
Aclaris Therapeutics Inc
8 Jun 21
Prospectus supplement for primary offering
4:25pm
at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 662∕3% of the outstanding voting … of authorized directors may call a special meeting of stockholders.
Our amended and restated bylaws also provide that stockholders seeking to present
S-3ASR
q8a0hzvn6p2cstxg384
20 May 21
Automatic shelf registration
4:56pm
424B5
37md1jrcjwm
20 Jan 21
Prospectus supplement for primary offering
5:00pm
424B5
eujf i2isxhsejleji
19 Jan 21
Prospectus supplement for primary offering
4:04pm
424B5
ol4evg69els7fh31qh
13 Aug 20
Prospectus supplement for primary offering
5:26pm
8-K
EX-3.1
6strnb unsfm
24 Jun 20
Amendments to Articles of Incorporation or Bylaws
5:00pm
424B5
chhsosdzk
29 Apr 20
Prospectus supplement for primary offering
4:03pm
424B5
uc0xyy7 3ypwsai4urz
18 Oct 18
Prospectus supplement for primary offering
4:08pm
424B5
jcifsy06cscexmddw pw
17 Oct 18
Prospectus supplement for primary offering
4:04pm